For much of the past two years, Wall Street treated long-run inflation expectations as the boring part of the macro story. Short-run prints whipped around. The five-year horizon stayed anchored. That assumption broke this…
Somewhere between a thought experiment and a margin call, SpaceX has a price. On Hyperliquid, a decentralized derivatives venue, a synthetic contract called SPCX-USD recently changed hands around $203. Plug that price into the…
In a Fortune interview published May 18, 2026, President Trump said something he has spent a year refusing to say. Asked about the path of interest rates, he allowed that “you can’t really look…
NextEra Energy (NYSE:NEE | NEE Price Prediction) announced on May 18, 2026 an all-stock agreement to acquire Dominion Energy (NYSE:D) for $67 billion, a figure the press release frames as the largest energy deal…
President Trump, talking to Fortune on May 18, 2026, did not bury the lede. “It really pisses me off,” he said of the Supreme Court ruling that struck down roughly half of last year’s…
The Vanguard Mega Cap Growth ETF (NYSEARCA:MGK) has 63 holdings, which sounds diversified until you check the weights. Five names carry almost 46% of the fund. The MGK pitch is straightforward exposure to U.S.…
Gavin Baker, the tech investor whose track record gives him an audience whenever he sits down with Patrick O’Shaughnessy, floated a number on a recent podcast that should make anyone modeling NVIDIA’s (NASDAQ:NVDA |…
The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) keeps rising more and more, no matter how “bad” the news gets. Since Election Day 2024, the index is up 30%, a run that has absorbed a…
You buy the iShares Russell 1000 Growth ETF (NYSEARCA:IWF) expecting broad growth exposure. The Russell 1000 Growth Index holds 391 names, and IWF tracks all of them. The catch is that roughly a third…
While American investors have spent the last decade celebrating the Magnificent Seven and paying premium multiples for U.S. growth, a quiet category of overseas stocks has been compounding in the shadows. The Fidelity International…
The Magnificent Seven question facing investors in 2026 is how to own these names. Roundhill Magnificent Seven ETF (NYSEARCA:MAGS) answers with one ticker holding all seven mega caps at equal weight, rebalanced quarterly so…
Warren Buffett sold more stock than he bought for 13 quarters before Greg Abel came in. The result sits on Berkshire’s balance sheet as a number that functions like a flare. Roughly $397 billion…
The pitch on the Vanguard Information Technology ETF (NYSEARCA:VGT) is sector breadth. You pay nine basis points, you get the entire information technology sleeve of the U.S. market, roughly $125 billion in assets aggregated…
If you bought AMZY at inception hoping to clip Amazon-sized income checks while still riding Amazon’s run, the numbers since October 2023 force an honest conversation. The YieldMax AMZN Option Income Strategy ETF (NYSEARCA:AMZY)…
YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY) distributes weekly amounts in the $0.37 to $0.52 range through 2026, an annualized run rate the fund’s marketing has pinned at 77%, 104%, even 117%. Those distributions…
It doesn’t matter if you’re 66 or 6 (you’re going places if you’re reading this at 6!), Social Security will matter for you. Unfortunately, the program is barreling down a path that could render…
YieldMax NVDA Option Income Strategy ETF (NYSEARCA:NVDY) sells the right to NVIDIA’s biggest up moves each month and hands you the option premium as income. The fund currently trades around $14 and manages $1.82…
The YieldMax MSTR Option Income Strategy ETF (NASDAQ:MSTY) trades near $24, and the trap in that number is what it has done while bitcoin spent most of the last year doing something else. MSTY…
During Nvidia’s (NASDAQ:NVDA | NVDA Price Prediction) Q4 FY2026 earnings call in late February this year, the company’s VP of Investor Relations said “Physical AI is here,” something that the company’s financials are also corroborating.…
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every healthcare benchmark anyway.…
